Non-Hodgkin lymphoma is a malign hematological disorder characterized by abundant proliferation of lymphoid organs. In some cases somatic mutations of the CASP10 gene are the reason.
1. |
Clementi R et al. (2005) A proportion of patients with lymphoma may harbor mutations of the perforin gene. |
2. |
Compagno M et al. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. |
3. |
Morin RD et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. |
4. |
Wiernik PH et al. (2000) Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma. |
5. |
Altieri A et al. (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. |
6. |
Lenz G et al. (2008) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. |
7. |
Davis RE et al. (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. |
8. |
Morin RD et al. (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. |
9. |
Pasqualucci L et al. (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. |
10. |
Scuoppo C et al. (2012) A tumour suppressor network relying on the polyamine-hypusine axis. |